Utku Oflazoğlu

456 total citations
41 papers, 312 citations indexed

About

Utku Oflazoğlu is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Utku Oflazoğlu has authored 41 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 10 papers in Cancer Research and 6 papers in Surgery. Recurrent topics in Utku Oflazoğlu's work include Inflammatory Biomarkers in Disease Prognosis (6 papers), Cancer, Lipids, and Metabolism (5 papers) and Nutrition and Health in Aging (5 papers). Utku Oflazoğlu is often cited by papers focused on Inflammatory Biomarkers in Disease Prognosis (6 papers), Cancer, Lipids, and Metabolism (5 papers) and Nutrition and Health in Aging (5 papers). Utku Oflazoğlu collaborates with scholars based in Türkiye, United States and United Kingdom. Utku Oflazoğlu's co-authors include Yüksel Küçükzeybek, Ahmet Alacacıoğlu, Tarık Salman, Yaşar Yıldız, Mustafa Oktay Tarhan, Umut Varol, Leyla Demir, İlhan Öztop, Murat Akyol and Umut Varol and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Utku Oflazoğlu

37 papers receiving 307 citations

Peers

Utku Oflazoğlu
Katerina Zakka United States
Utku Oflazoğlu
Citations per year, relative to Utku Oflazoğlu Utku Oflazoğlu (= 1×) peers Katerina Zakka

Countries citing papers authored by Utku Oflazoğlu

Since Specialization
Citations

This map shows the geographic impact of Utku Oflazoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Utku Oflazoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Utku Oflazoğlu more than expected).

Fields of papers citing papers by Utku Oflazoğlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Utku Oflazoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Utku Oflazoğlu. The network helps show where Utku Oflazoğlu may publish in the future.

Co-authorship network of co-authors of Utku Oflazoğlu

This figure shows the co-authorship network connecting the top 25 collaborators of Utku Oflazoğlu. A scholar is included among the top collaborators of Utku Oflazoğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Utku Oflazoğlu. Utku Oflazoğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yıldız, Yaşar, et al.. (2025). Clinical significance of urotensin 2 plasma level in patients diagnosed with prostate cancer.. Journal of Clinical Oncology. 43(5_suppl). 249–249. 1 indexed citations
3.
Salman, Tarık, et al.. (2024). Treatment Strategies for Glioblastoma Multiforme: A Single Center Experience. 10(1). 9–16. 1 indexed citations
4.
Demir, Leyla & Utku Oflazoğlu. (2023). The relationship between sarcopenia and serum irisin and TNF-α levels in newly diagnosed cancer patients. Supportive Care in Cancer. 31(10). 586–586. 7 indexed citations
5.
Çakır, Ebru, et al.. (2022). Atypical Presentation of a Primary Thymic Adenocarcinoma. Journal of College of Physicians And Surgeons Pakistan. 32(8). S141–S143.
6.
Oflazoğlu, Utku, Umut Varol, Tarık Salman, et al.. (2022). The relationship between sarcopenia detected in newly diagnosed colorectal cancer patients and FGF21, irisin and CRP levels. European Geriatric Medicine. 13(4). 795–803. 15 indexed citations
7.
Alacacıoğlu, Ahmet, Utku Oflazoğlu, Yaşar Yıldız, et al.. (2022). HALP score and GNRI: Simple and easily accessible indexes for predicting prognosis in advanced stage NSCLC patients. The İzmir oncology group (IZOG) study. Frontiers in Nutrition. 9. 905292–905292. 35 indexed citations
8.
Demir, Leyla, Umut Varol, Kemal Atahan, et al.. (2020). Preliminary study of serum Galectin-1 in breast cancer carcinogenesis [Izmir Oncology Group (IZOG) study].. Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 25(2). 675–680. 3 indexed citations
9.
Oflazoğlu, Utku, Ahmet Alacacıoğlu, Umut Varol, et al.. (2019). Prevalence and related factors of sarcopenia in newly diagnosed cancer patients. Supportive Care in Cancer. 28(2). 837–843. 20 indexed citations
10.
Oflazoğlu, Utku, Ahmet Alacacıoğlu, Umut Varol, et al.. (2019). Chemotherapy-induced sarcopenia in newly diagnosed cancer patients: Izmir Oncology Group (IZOG) study. Supportive Care in Cancer. 28(6). 2899–2910. 14 indexed citations
11.
12.
Oktay, Esin, Utku Oflazoğlu, Yelda Varol, et al.. (2018). The prognostic role of thyroid transcription factor-1 in lung adenocarcinoma. Journal of Cancer Research and Therapeutics. 16(4). 737–737. 8 indexed citations
13.
Alacacıoğlu, Ahmet, Yüksel Küçükzeybek, Umut Varol, et al.. (2018). Is monitoring mean platelet volume necessary in breast cancer patients?. Open Medicine. 13(1). 450–455. 1 indexed citations
14.
Salman, Tarık, Leyla Demir, Umut Varol, et al.. (2017). Serum apelin levels and body composition changes in breast cancer patients treated with an aromatase inhibitor.. PubMed. 21(6). 1419–1424. 18 indexed citations
15.
Salman, Tarık, Umut Varol, Utku Oflazoğlu, et al.. (2016). Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Patients with Neuroendocrine Tumors: An Izmir Oncology Group Study. Chemotherapy. 61(6). 281–286. 46 indexed citations
16.
Yıldız, Yaşar, Murat Akyol, Ahmet Alacacıoğlu, et al.. (2016). Sexual satisfaction, anxiety, depression and quality of life amoung Turkish gynecological cancer patients. Annals of Oncology. 27. vi306–vi306. 4 indexed citations
17.
Oflazoğlu, Utku, Ahmet Alacacıoğlu, Işıl Somali, et al.. (2016). Prognostic value of neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR) and mean platelet volume (MPV) in patients with colorectal carcinoma [Izmir Oncology Group (IZOG) study]. Annals of Oncology. 27. vi197–vi197. 6 indexed citations
18.
Salman, Tarık, Tuğba Yavuzşen, Işıl Somali, et al.. (2016). Evalution of Central Venous Catheter Ports Placed by Medical Oncologists: A Single Center Experience. Acta Oncologica Turcica. 49(2). 102–110. 3 indexed citations
19.
Akman, Tülay, İlhan Öztop, Yasemin Baskın, et al.. (2014). The role of BRAF mutation in patients with high-risk malignant melanoma treated with high-dose adjuvant interferon therapy. Medical Oncology. 32(1). 440–440. 6 indexed citations
20.
Berk, Velı, Kaplan Ma, Süleyman Buyukberber, et al.. (2013). Efficiency and Side Effects of Sorafenib Therapy for Advanced Hepatocellular Carcinoma: A Retrospective Study by the Anatolian Society of Medical Oncology. Asian Pacific Journal of Cancer Prevention. 14(12). 7367–7369. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026